Powered by

-Retrophin to Present at the Leerink Partners 7th Annual Global Healthcare Conference

Feb 05, 2018 - ENP Newswire

SAN DIEGO - Retrophin, Inc. (NASDAQ: RTRX) today announced that Stephen Aselage, chief executive officer, will present at the Leerink Partners 7th Annual Global Healthcare Conference in New York City on Thursday, February 15, 2018 at 9:00 a.m. ET.

A live webcast of the presentation will be available at ir.retrophin.com/events and an archived replay will be accessible for up to 30 days.

About Retrophin

Retrophin is a biopharmaceutical company specializing in identifying, develop...